Department of Defense Pharamacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
SAM.GOV Due: June 20, 2025 at 05:00 PM UTC
In-Active Solicitation Source Url

Summary

The Department of Defense is seeking quotations for the Uniform Formulary Blanket Purchase Agreement (UF BPA) and the Uniform Formulary Additional Discount Program (UF ADP) as part of its integrated pharmacy benefits program for the Military Health System. This solicitation is aimed at pharmaceutical companies that can provide competitive pricing for specific drug classes that will be reviewed by the Pharmacy and Therapeutics Committee. The selected contractors will be responsible for supplying pharmaceutical agents that meet the clinical and cost-effectiveness criteria established by the DoD. Companies interested in this opportunity should have experience in pharmaceutical pricing and be able to navigate the complexities of government contracting, particularly in the healthcare sector.
Description

The Department of Defense (DoD) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21

Entities
DOD
Department of Defense
DHA(
Defense Health Agency
NAICS
325412
Set Aside
None
Place of Performance
San Antonio , Texas 78230
Point of Contact
Full Name Email Phone Type
Tracy Banks [email protected] primary
Julianne Canaley [email protected] secondary
Attachments
  • Price+List+-+Vyvgart+Hytrulo+-+Neurological+Agents+Misc+-+NA.xlsx
  • RFQ+HT9402-25-Q-9303+NAD.pdf
  • Price+Appendix+FAQ+NAD.pdf
  • Price+List+-+ustekinumab-Centocor+-+TIBs+-+IL-23.xlsx
  • DoD+Formulary+Placement+of+FDA+Newly+Approved+Drugs.pdf
  • Price+List+-+Hemiclor+-+Diuretics+-+NA.xlsx
  • Price+List+-+Symbravo+-+Migraine+Agents+-+Triptans.xlsx
  • Price+List+-+umeclidinium-vilanterol+-+Pulmonary-2+Agents+-+COPD.xlsx
  • Amendment+01+RFQ2+NAD.pdf
  • A-1+Price+List+-+ustekinumab+-+TIBs+-+IL-23.xlsx